-
1
-
-
22844432208
-
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005)
-
on behalf of the BHIVA Writing Committee. published online July 1. DOI:10.1111/j.1468-1293.2005.0311b.x
-
Gazzard B., and on behalf of the BHIVA Writing Committee. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005). HIV Med (2005). published online July 1. DOI:10.1111/j.1468-1293.2005.0311b.x
-
(2005)
HIV Med
-
-
Gazzard, B.1
-
3
-
-
3042726798
-
Treatment of adult HIV infection. 2004 recommendations of the International AIDS Society-USA panel
-
Yeni P., Hammer S., Hirsch M., et al. Treatment of adult HIV infection. 2004 recommendations of the International AIDS Society-USA panel. JAMA 292 (2004) 251-265
-
(2004)
JAMA
, vol.292
, pp. 251-265
-
-
Yeni, P.1
Hammer, S.2
Hirsch, M.3
-
4
-
-
0035071409
-
An open-label randomized trial to evaluate different therapeutic strategies of combination therapy in HIV-1 infection: design, rationale, and methods of the initio trial
-
INITIO Co-ordinating Committee
-
INITIO Co-ordinating Committee. An open-label randomized trial to evaluate different therapeutic strategies of combination therapy in HIV-1 infection: design, rationale, and methods of the initio trial. Control Clin Trials 22 (2001) 160-175
-
(2001)
Control Clin Trials
, vol.22
, pp. 160-175
-
-
-
6
-
-
0344149561
-
Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection
-
Shafer R., Smeaton L., Robbins G., et al. Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection. N Engl J Med 349 (2003) 2304-2315
-
(2003)
N Engl J Med
, vol.349
, pp. 2304-2315
-
-
Shafer, R.1
Smeaton, L.2
Robbins, G.3
-
7
-
-
0345012053
-
Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection
-
for the AIDS Clinical Trials Group 384 Team
-
Robbins G., De Gruttola V., Shafer R., et al., for the AIDS Clinical Trials Group 384 Team. Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection. N Engl J Med 349 (2003) 2293-2303
-
(2003)
N Engl J Med
, vol.349
, pp. 2293-2303
-
-
Robbins, G.1
De Gruttola, V.2
Shafer, R.3
-
9
-
-
0003730887
-
-
Division of AIDS (accessed Feb 28, 2006)
-
Division of AIDS. Table for grading severity of adult adverse experiences (August, 1992). http://rcc.tech-res-intl.com/DAIDS%20RCC%20Forms/TB_ToxicityTables_Adult_TRP_v01a.pdf (accessed Feb 28, 2006)
-
(1992)
Table for grading severity of adult adverse experiences
-
-
-
11
-
-
0037092125
-
Quality control of CD4+ T-lymphocyte enumeration: results from the last 9 years of the United Kingdom National External Quality Assessment Scheme for Immune Monitoring (1993-2001)
-
Whitby L., Granger V., Storie I., et al. Quality control of CD4+ T-lymphocyte enumeration: results from the last 9 years of the United Kingdom National External Quality Assessment Scheme for Immune Monitoring (1993-2001). Cytology 50 (2002) 102-110
-
(2002)
Cytology
, vol.50
, pp. 102-110
-
-
Whitby, L.1
Granger, V.2
Storie, I.3
-
12
-
-
0027122957
-
1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
-
US Centers for Disease Control and Prevention
-
US Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41 (1992) 1-19
-
(1992)
MMWR Recomm Rep
, vol.41
, pp. 1-19
-
-
-
13
-
-
0032895405
-
Clinical trials using HIV-1 RNA-based primary endpoints: statistical analysis and potential biases
-
Marschner I., Betensky R., DeGruttola V., Hammer S., and Kuritzkes D. Clinical trials using HIV-1 RNA-based primary endpoints: statistical analysis and potential biases. J AIDS 20 (1999) 220-227
-
(1999)
J AIDS
, vol.20
, pp. 220-227
-
-
Marschner, I.1
Betensky, R.2
DeGruttola, V.3
Hammer, S.4
Kuritzkes, D.5
-
14
-
-
33644792666
-
Update of the drug resistance mutations in HIV-1: fall 2005
-
Johnson V., Brun-Vezinet F., Clotet B., et al. Update of the drug resistance mutations in HIV-1: fall 2005. Top HIV Med 13 (2005) 125-131
-
(2005)
Top HIV Med
, vol.13
, pp. 125-131
-
-
Johnson, V.1
Brun-Vezinet, F.2
Clotet, B.3
-
15
-
-
0035075985
-
The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial
-
for the CPCRA 058 FIRST Trial Study Team
-
MacArthur R., Chen L., Mayers D., et al., for the CPCRA 058 FIRST Trial Study Team. The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial. Control Clin Trials 22 (2001) 176-190
-
(2001)
Control Clin Trials
, vol.22
, pp. 176-190
-
-
MacArthur, R.1
Chen, L.2
Mayers, D.3
-
16
-
-
0037182766
-
Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection
-
for the M98-863 study team
-
Walmsley S., Bernstein B., King M., et al., for the M98-863 study team. Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection. N Engl J Med 346 (2002) 2039-2046
-
(2002)
N Engl J Med
, vol.346
, pp. 2039-2046
-
-
Walmsley, S.1
Bernstein, B.2
King, M.3
-
17
-
-
0032566194
-
1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals
-
on behalf of the BHIVA Guidelines Writing Committee
-
Gazzard B., Moyle G., and on behalf of the BHIVA Guidelines Writing Committee. 1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet 352 (1998) 314-316
-
(1998)
Lancet
, vol.352
, pp. 314-316
-
-
Gazzard, B.1
Moyle, G.2
-
18
-
-
33746008822
-
-
Pollard R, Peterson D, Hardy D, et al. Stavudine (d4T) and didanosine (ddI) combination therapy in HIV-infected subjects: antiviral effect and safety in an on-going pilot randomized double-blinded trial. Vancouver: XI International AIDS Conference, 1996: abstract Th.B.293.
-
-
-
-
19
-
-
0003176164
-
HIV treatment guidelines
-
US Centers for Disease Control and Prevention
-
US Centers for Disease Control and Prevention. HIV treatment guidelines. MMWR Recomm Rep 47 (1998) 1-41
-
(1998)
MMWR Recomm Rep
, vol.47
, pp. 1-41
-
-
-
20
-
-
0038324248
-
Where now for Trizivir? Role of the triple-NRTI pill post-ACTG 5095
-
Moyle G. Where now for Trizivir? Role of the triple-NRTI pill post-ACTG 5095. AIDS Read 13 (2003) 223-227
-
(2003)
AIDS Read
, vol.13
, pp. 223-227
-
-
Moyle, G.1
|